Alterd
Open in App
LSD

LSD

Open in the ALTERD app
Download on the
App Store
Get it on
Google Play

Lysergic acid diethylamide (LSD) is a micro-gram-potent ergoline first synthesized in 1938 and self-tested by Swiss chemist Albert Hofmann on 19 April 1943 (“Bicycle Day”).

It acts mainly as a partial 5-HT₂A agonist, loosening the brain’s default-mode network and promoting vivid sensory-emotional cross-talk.

Modern enthusiasts micro-dose for focus, macro-dose for mystical insight, and researchers revisit LSD for anxiety, depression, and cluster-headache therapy.

Despite promising data, LSD remains Schedule I in the United States and is controlled under the 1971 UN Convention, requiring careful harm-reduction for non-clinical use.

2 Dosage & Effect Range

3 In-Session Practices: Framing & Flow

4 Subjective Effects & Experience

Onset appears 20 – 60 minutes after ingestion, peaks at 2 – 4 hours, and tapers over 8 – 12 hours, with a subtle after-glow into the next day.

Users report kaleidoscopic visuals, sound–colour synaesthesia, elastic time perception, and intensified emotions that mirror the surrounding mindset.

Neuro-imaging shows default-mode network “disintegration,” correlating with ego-dissolution and boundary loss.

Cognitive loops and novel associative thinking make LSD a double-edged tool for creativity and rumination.

5 Safety & Risk Reduction

6 Cultural Significance, Historical & Traditional Use

Hofmann’s “Bicycle Day” sparked the psychedelic era, and Timothy Leary’s “turn on, tune in, drop out” became a 1960s counter-culture mantra.

LSD influenced music (The Beatles, Grateful Dead), art (psychedelic posters), and computer-age pioneers (many Silicon Valley innovators credit micro- or macro-dosing for creative breakthroughs).

CIA’s covert MK-Ultra program and the 1970 Controlled Substances Act halted research for decades, but today’s decriminalisation efforts (e.g., Portugal 2001) mark a gradual policy shift.

7 Legality

8 Chemistry & Mechanism of Action

LSD (C₂₀H₂₅N₃O) is an indole-based ergoline; its diethylamide tail aids blood-brain penetration.

It binds with picomolar affinity to 5-HT₂A, 5-HT₂C, and at higher doses dopamine D₂ receptors, producing cascading cortical dis-inhibition and heightened global connectivity.

Crystal-structure studies reveal an extracellular “lid” on 5-HT₂B that explains LSD’s long receptor dwell-time and extended trip duration.

9 Pharmacokinetics & Methods of Use

10 Scientific Research & Emerging Studies

Swiss double-blind work (200 µg LSD + psychotherapy) showed sustained anxiety relief a year after dosing.

2-bromo-LSD, a non-hallucinogenic analogue, reduced cluster-headache frequency in recent pilot studies.

MindMed’s MM-120 (optimised LSD) met primary endpoints in a 2024 Phase-2b trial for generalised anxiety disorder and received FDA Breakthrough-Therapy designation.

Functional MRI consistently links LSD to reduced default-mode connectivity and enhanced global network integration, supporting its trans-diagnostic therapeutic promise.

11 Notable Figures in Media & Science

12 FAQ, Fun Facts & Myths

More Fun Facts

How LSD Led to a Nobel Prize

Sources